KPIs & Consensus Expectations

Key Takeaway: Consensus sits at a manageable bar — brokerage organic growth of ~4.9% is right in line with management's 5% guide, and adjusted EPS of $1.77 is modestly below the implied run-rate. Risk Management organic growth (guided to 11%) is the bigger swing factor given the upward revision at the June Investor Day.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Q1 2026 Actual

Q2 2025 Actual

Q2 2026 Consensus Estimate

YoY Change

Q2 2026 Guidance

Consensus vs. Guidance

Adjusted EPS - Diluted - Operating ($)

$4.47

$2.33

$1.77

-24% (Q1 seasonally strongest)

~$1.80 implied (mgmt commentary)

~-2%

Brokerage Organic Revenue Growth (%)

4.2%

4.7%

~4.9%

+20 bps

~5%

~-10 bps (in-line)

Adjusted EBITDAC Margin - Brokerage (%)

40.1%

36.4%

~33.1%

-330 bps (seasonal)

Unchanged from April; 40-60 bps underlying expansion FY

In-line

Revenue - Brokerage & Risk Mgmt - Operating ($M)

$4,756M

$3,214M

~$4,023M

+25% (AP acquisition)

N/A (no explicit revenue guide)

N/A

EBITDAC - Brokerage & Risk Mgmt - Operating ($M)

$1,813M

$1,095M

~$1,267M

+16% (AP acquisition)

AP EBITDA outlook unchanged from April

In-line

Risk Management Organic Growth (%)

10.0%

N/A — not in VA

N/A — not in VA

N/A

~11% (raised at June Investor Day)

N/A

Sources: Visible Alpha Consensus and Actuals Data; AJG Q1 2026 Earnings Release (April 30, 2026); AJG Pre-Q2 Investor Meeting (June 17, 2026). All VA-sourced figures cited per Visible Alpha dataset.

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)

KPI 1: Adjusted EPS - Diluted - Operating

Quarter

Reported

Consensus

Surprise %

Result

Q1 2026

$4.47

$4.43

+0.9%

Beat

Q4 2025

$2.38

$2.32

+2.6%

Beat

Q3 2025

$2.32

$2.47

-6.1%

Miss

Q2 2025

$2.33

$2.32

+0.4%

In-Line / Slight Beat

Q1 2025

$3.68

$3.52

+4.5%

Beat

Q4 2024

$2.13

$1.99

+7.0%

Beat

Q3 2024

$2.25

$2.24

+0.5%

In-Line / Slight Beat

Q2 2024

$2.33

$2.32

+0.4%

In-Line / Slight Beat

KPI 2: Brokerage Organic Revenue Growth (%)

Quarter

Reported

Consensus

Surprise (bps)

Result

Q1 2026

4.2%

4.6%

-40 bps

Slight Miss

Q4 2025

4.5%

3.4%

+110 bps

Beat

Q3 2025

3.9%

5.0%

-110 bps

Miss

Q2 2025

4.7%

5.4%

-70 bps

Slight Miss

Q1 2025

9.1%

8.4%

+70 bps

Beat

Q4 2024

7.8%

7.8%

0 bps

In-Line

Q3 2024

5.4%

6.2%

-80 bps

Slight Miss

Q2 2024

4.7%

5.4%

-70 bps

Slight Miss

Pattern: AJG has a strong track record of beating on adjusted EPS (7 of last 8 quarters), but brokerage organic growth has more frequently come in at or below consensus (5 of last 8 quarters), reflecting the difficulty of forecasting property market pricing dynamics. The Q3 2025 EPS miss was an outlier driven by AssuredPartners integration noise. Source: Visible Alpha Consensus and Actuals Data.

Guidance & Commentary Evolution

Key Takeaway: Since the April 30 Q1 earnings call, management has raised two key guidance items — AssuredPartners synergy targets (to $325M from $300M) and Risk Management organic growth (to 11% Q2 / 8% FY) — while holding brokerage organic and margin guidance unchanged. Tone has shifted more constructive.

Metric

Initial Guidance (Q1 Earnings Call, Apr 30)

Revised Guidance

Current Consensus

Note

Brokerage Organic Growth — Q2 2026

~5%

~4.9%

Unchanged; CFO stated "further confidence" at June 17 Investor Day

Brokerage Organic Growth — FY 2026

~5.5%

~5.0%

Unchanged; pricing ~1 pt of organic, net new business ~3 pts

Risk Management Organic Growth — Q2 2026

~10% (similar to Q1)

~11%

N/A — not in VA

↑ Raised at June 17 Investor Day; driven by large new business wins and international growth

Risk Management Organic Growth — FY 2026

~7% (unchanged from March IR Day)

~8%

N/A — not in VA

↑ Raised at June 17 Investor Day; more confident on new business pipeline

AssuredPartners Synergy Run-Rate (by early 2028)

Up to $300M

Up to $325M

N/A

↑ Raised at June 17 Investor Day; back-office systems nearly fully implemented, vendor/real estate consolidations ahead of plan

AssuredPartners EBITDA Outlook — Q2 & FY 2026

Per April CFO Commentary

~$1,267M (EBITDAC, B&RM)

Unchanged; "integration story continues to improve"

Brokerage EBITDAC Margin — FY 2026 Underlying Expansion

40–60 bps underlying expansion

~33.1% Q2 consensus

Unchanged; "no new news" per CFO at June 17 Investor Day

Share Repurchases — Q2 2026

In quiet period; no Q2 buybacks at time of Q1 call

~$170M repurchased in Q2 (disclosed June 17)

N/A

↑ Disclosed at June 17 Investor Day; opportunistic given management view equity is undervalued

M&A Pipeline

>40 term sheets, ~$400M annualized revenue

~40 term sheets, ~$600M annualized revenue

N/A

↑ Pipeline grew; 15 mergers closed YTD 2026 representing ~$115M annualized revenue

Sources: AJG Q1 2026 Earnings Call Transcript (April 30, 2026); AJG Pre-Q2 Investor Meeting with Management (June 17, 2026); AJG 8-K (June 17, 2026).

Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have drifted modestly lower since the Q1 print — Q2 EPS consensus is down ~5% from the post-Q1 baseline — but this appears to reflect dilution from the share repurchase timing and integration noise rather than fundamental deterioration. The gap between current consensus and management's implied trajectory represents a modest cushion heading into the print.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (May 7, 2026)

Current Consensus (July 29, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call, Apr 30)

Current Guidance (June 17 Investor Day)

Guidance Δ

Consensus vs. Guidance (%)

Adj. EPS - Operating (Q2 2026)

$1.86

$1.77

-4.8%

~$1.80 implied

~$1.80 implied (unchanged)

Flat

~-2% (slight cushion)

Brokerage Organic Growth (Q2 2026)

~4.9%

~4.9%

Flat

~5%

~5% (unchanged; "further confidence")

Flat

~-10 bps (in-line)

Adj. EPS - Operating (FY 2026)

$13.21

$13.14

-0.5%

N/A (no explicit FY EPS guide)

N/A

N/A

N/A

Brokerage Organic Growth (FY 2026)

~5.0%

~5.0%

Flat

~5.5%

~5.5% (unchanged)

Flat

~-50 bps (modest cushion)

EBITDAC - B&RM Operating (Q2 2026, $M)

~$1,269M

~$1,267M

-0.2%

AP EBITDA unchanged from April

Unchanged

Flat

In-line

Commentary: The modest ~5% downward drift in Q2 EPS consensus since the Q1 print is largely attributable to the timing of share repurchases (Q2 buybacks of ~$170M were not anticipated at the time of the Q1 call) and integration-related noise, rather than any deterioration in underlying business trends. Brokerage organic growth estimates have been remarkably stable, consistent with management's unchanged 5% Q2 guide. The FY 2026 consensus organic growth of ~5.0% sits ~50 bps below management's 5.5% guide, representing a cushion that could be closed if H2 execution is strong. Source: Visible Alpha Consensus and Actuals Data.

Stock Performance

Key Takeaway: AJG has rallied ~30% from its post-Q1 lows, significantly outperforming both the insurance sector ETF (KIE, +15%) and the S&P 500 (+2%) since the April 30 earnings date. The move has been driven almost entirely by multiple re-expansion (EV/EBITDA expanded from ~12x to ~14x over 3 months), not estimate revisions, suggesting the stock has priced in a clean execution story and leaves limited room for disappointment.

AJG vs. KIE (Insurance Sector ETF) vs. S&P 500 — Indexed to 100 at April 30, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance / Stock Price Data.

Performance Summary (April 30 – July 29, 2026):

Security

Price at Q1 Earnings (Apr 30)

Price (Jul 29, 2026)

Return Since Q1 Earnings

AJG

$206.40

~$268.95 (Jul 28 close)

+30.3%

KIE (Insurance Sector ETF)

$57.33

~$66.45 (Jul 28 close)

+15.9%

S&P 500 (SPY)

$718.66

~$740.86 (Jul 28 close)

+3.1%

Key Events Since Q1 Earnings:

Valuation Context: AJG currently trades at ~26.6x NTM P/E and ~13.9x NTM EV/EBITDA. The 3-month multiple expansion of ~+16% on EV/EBITDA (from ~12x to ~14x) has been the primary driver of the stock's outperformance, with estimate revisions contributing minimally. This multiple re-rating reflects growing market confidence in the AssuredPartners integration and synergy trajectory, but also raises the bar for the Q2 print. Source: Stock Price Data (Yahoo Finance); Visible Alpha Consensus and Actuals Data.

Peer Commentaries & Q2 2026 Read-Throughs

Key Takeaway: Peer commentary from AON (reported July 29) and BRO (reported July 28) provides a mixed-to-positive read-through for AJG's Q2 print. AON's 5% organic growth beat and reaffirmed guidance is the most directly positive signal; BRO's organic revenue decline of -0.7% is a negative read-through but is heavily distorted by cat property exposure and company-specific factors. All commentary below is strictly from Q2 2026 reporting or post-Q1 2026 commentary about the current quarter.

Note: Only commentary about Q2 2026 (the current reporting period) is included below. Prior-quarter retrospective commentary has been excluded.

AON (AON) — Q2 2026 Earnings (Reported July 29, 2026)

Read-Through: POSITIVE

Brown & Brown (BRO) — Q2 2026 Earnings (Reported July 28, 2026)

Read-Through: MIXED / NEGATIVE (with important caveats)

Summary Read-Through Table

Peer

Signal

Key Data Point

AJG Read-Through

AON — Organic Growth (Q2 2026)

POSITIVE

+5% across all segments; beat consensus of ~4.8%

Validates AJG's ~5% brokerage organic guide; demand environment healthy

AON — Net New Business (Q2 2026)

POSITIVE

10-pt contribution for 9th consecutive quarter

Supports AJG's ~3 pts net new business contribution to organic growth

AON — Margin Expansion (Q2 2026)

POSITIVE

+70 bps adjusted operating margin; in-line with FY guide

Positive read-through for AJG's 40–60 bps underlying expansion target

AON — Reinsurance (Q2 2026)

POSITIVE

+5% organic despite 15–20% lower treaty rates; new business wins offset

Positive for Gallagher Re, which had strong start to 2026

AON — Full-Year Guidance (Q2 2026)

POSITIVE

Reaffirmed mid-single-digit or greater organic; 70–80 bps margin expansion

Sector demand environment remains supportive for AJG's FY 5.5% guide

BRO — Organic Revenue (Q2 2026)

MIXED

-0.7% organic (vs. +0.5% consensus); distorted by litigation, timing, pharmacy

Negative headline but company-specific; AJG less exposed to these factors

BRO — Cat Property Pricing (Q2 2026)

NEGATIVE

Cat property rates -15% to -35%, similar to Q1

Confirms property headwind AJG has already guided for; no incremental surprise

BRO — Casualty Pricing (Q2 2026)

POSITIVE

Primary casualty/professional liability up ~5%; excess under more pressure

Consistent with AJG's casualty data; supports organic growth ex-property

BRO — H2 2026 Organic Outlook

POSITIVE

Retail 1.5–2.5%, Specialty 2–4% in H2

Positive for sector H2 momentum; AJG guiding 5–6% in Q3/Q4

BRO — Macro / Client Activity (Q2 2026)

NEUTRAL

Stable spending, neutral hiring, positive audit premium activity

Consistent with AJG's mid-June daily revenue indications in "positive territory"

Sources: AON Q2 2026 Earnings Release and Earnings Call Transcript (July 29, 2026); BRO Q2 2026 Earnings Release and Earnings Call Transcript (July 28, 2026).

Material News & Developments

Key Takeaway: The most important development since the Q1 print is the June 17 Investor Day, where management raised AssuredPartners synergy targets and Risk Management guidance — a clear positive signal for the Q2 print. The July 29 board change is a neutral governance event.

Insider Transaction Activity

Key Takeaway: Insider activity since the Q1 earnings print is minimal — only one open-market sale was identified (Controller/CAO Richard Cary, June 2, 2026, $618K, discretionary). The absence of clustered selling or unusual transaction sizes is a neutral-to-positive signal; no open-market buys were filed. The single discretionary sale by the Controller is not a meaningful signal given its modest size relative to the stock's move.

Name

Title

Transaction Type

Value

Date

Note

Richard C. Cary

Controller, CAO

Open Market Sale

$618,000 (3,000 shares @ ~$206)

June 2, 2026

Discretionary sale; no 10b5-1 plan indicated. Modest size; sold near post-Q1 lows. Not a meaningful signal.

Note: The remaining Form 4 filings reviewed for the period (17 total filings) consisted of equity award grants, vesting events, and tax withholding transactions — not open-market buys or sells. No 10b5-1 plan initiations were identified in the review period. The absence of insider buying despite management's stated view that equity is "woefully undervalued" is notable but may reflect the company's quiet period policy and ongoing M&A activity. Source: SEC Form 4 filings (AJG, April 30 – July 29, 2026).